[Physiopathologic modifications in the myocardial levels of adenine nucleotides]. 1984

A Rossi, and J Aussedat, and N Lavanchy

When the equilibrium between energy production and utilization is disrupted in the myocardium, the metabolism of adenine nucleotides is greatly altered. The first alteration is a change in the degree of phosphorylation which induces alterations in the respective amounts of AMP, ADP and ATP. This change, in turn, creates an imbalance between synthesis and degradation of adenine nucleotides. As a consequence, the levels of AMP, ADP and ATP are not restored when physiological conditions are reestablished. The aim of this paper is to describe the alterations of adenine nucleotides which occur in physiopathological conditions (ischemia, hypertrophy) and to discuss the use of the levels of AMP, ADP and ATP as indicators of the metabolic state of the heart. Brief descriptions of the methods used for determinations of concentrations and of the processes of energy transfer and adenine nucleotide synthesis in the myocardium are given.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D003402 Creatine Kinase A transferase that catalyzes formation of PHOSPHOCREATINE from ATP + CREATINE. The reaction stores ATP energy as phosphocreatine. Three cytoplasmic ISOENZYMES have been identified in human tissues: the MM type from SKELETAL MUSCLE, the MB type from myocardial tissue and the BB type from nervous tissue as well as a mitochondrial isoenzyme. Macro-creatine kinase refers to creatine kinase complexed with other serum proteins. Creatine Phosphokinase,ADP Phosphocreatine Phosphotransferase,ATP Creatine Phosphotransferase,Macro-Creatine Kinase,Creatine Phosphotransferase, ATP,Kinase, Creatine,Macro Creatine Kinase,Phosphocreatine Phosphotransferase, ADP,Phosphokinase, Creatine,Phosphotransferase, ADP Phosphocreatine,Phosphotransferase, ATP Creatine
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D004735 Energy Transfer The transfer of energy of a given form among different scales of motion. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed). It includes the transfer of kinetic energy and the transfer of chemical energy. The transfer of chemical energy from one molecule to another depends on proximity of molecules so it is often used as in techniques to measure distance such as the use of FORSTER RESONANCE ENERGY TRANSFER. Transfer, Energy
D006331 Heart Diseases Pathological conditions involving the HEART including its structural and functional abnormalities. Cardiac Disorders,Heart Disorders,Cardiac Diseases,Cardiac Disease,Cardiac Disorder,Heart Disease,Heart Disorder
D006332 Cardiomegaly Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES. Cardiac Hypertrophy,Enlarged Heart,Heart Hypertrophy,Heart Enlargement,Cardiac Hypertrophies,Enlargement, Heart,Heart Hypertrophies,Heart, Enlarged,Hypertrophies, Cardiac,Hypertrophies, Heart,Hypertrophy, Cardiac,Hypertrophy, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Rossi, and J Aussedat, and N Lavanchy
May 1951, The Journal of clinical investigation,
A Rossi, and J Aussedat, and N Lavanchy
January 1976, Recent advances in studies on cardiac structure and metabolism,
A Rossi, and J Aussedat, and N Lavanchy
April 1977, Chirurgisches Forum fur experimentelle und klinische Forschung,
A Rossi, and J Aussedat, and N Lavanchy
January 1977, Advances in experimental medicine and biology,
A Rossi, and J Aussedat, and N Lavanchy
April 1985, Rinsho byori. The Japanese journal of clinical pathology,
A Rossi, and J Aussedat, and N Lavanchy
January 1980, Journal de physiologie,
A Rossi, and J Aussedat, and N Lavanchy
March 1984, Brain research,
A Rossi, and J Aussedat, and N Lavanchy
December 1970, Biochemical medicine,
A Rossi, and J Aussedat, and N Lavanchy
January 1991, Neurologia (Barcelona, Spain),
A Rossi, and J Aussedat, and N Lavanchy
December 1991, Journal of molecular and cellular cardiology,
Copied contents to your clipboard!